Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Intrinsic Value
Hapvida Participações e Investimentos SA operates hospitals and clinics. [ Read More ]
The intrinsic value of one
HAPV3
stock under the Base Case scenario is
6.33
BRL.
Compared to the current market price of 3.85 BRL,
Hapvida Participacoes e Investimentos SA
is
Undervalued by 39%.
Hapvida Participacoes e Investimentos SA's market capitalization is 28.9B BRL.
HAPV3 stock price is 3.85 BRL.
HAPV3 stock price (3.85 BRL) is 39% less than its Intrinsic Value (6.33 BRL).
HAPV3 stock price (3.85 BRL) is 64% less than its Relative Value (10.75 BRL). Open Relative Valuation
HAPV3 has upside potential of 53% compared to the average analyst price target.
Open Wall St Estimates
HAPV3 has positive Net Debt. This means that the company has more debt (12B BRL) than cash and short-term investments (7B BRL).
HAPV3 has positive Free Cash Flow for the last twelve months.
HAPV3's Revenue has grown by 15% over the past 12 months.
HAPV3's short-term assets (11B BRL) exceed its short-term liabilties (9B BRL).
HAPV3's Revenue is forecast to grow at a rate of 9% per year over the next 3 years.
HAPV3's ROIC (Return on Invested Capital) has decreased in the last 3 years from 8% to 2%.
HAPV3 has positive Operating Income for the last twelve months.
HAPV3's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 2%.
HAPV3's ROE (Return on Equity) has significantly decreased in the last 3 years from 10% to -2%.
HAPV3's ROE (Return on Equity) for the past 12 months is negative and is equal to -2%.
HAPV3 has negative Net Income for the last twelve months.
HAPV3 has positive Gross Profit for the last twelve months.
HAPV3 has a very low three-year average ROIC (Return on Invested Capital): 3%. The company is not efficient at using invested capital to generate operating income.
HAPV3 has a very low three-year average ROE (Return on Equity): 2%. The company is not efficient at transforming stockholders' equity into net income.
HAPV3's Revenue has been growing by an exceptional 47% per year for the last 3 years.
HAPV3's long-term assets (75B BRL) exceed its long-term liabilties (26B BRL).
HAPV3's Altman Z-Score is very low and is equal to 1.3.
HAPV3's D/E (Debt to Equity) is very low and is equal to 0.25.
HAPV3 doesn't generate enough operating income (997m BRL) to safely cover interest payments on its debt (1B BRL).
Valuation Backtest
Hapvida Participacoes e Investimentos SA
Run backtest to discover the historical profit from buying and selling
HAPV3
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Hapvida Participacoes e Investimentos SA
Balance Sheet Decomposition
Hapvida Participacoes e Investimentos SA
| Current Assets | 10.5B |
| Cash & Short-Term Investments | 7B |
| Receivables | 2.4B |
| Other Current Assets | 1.1B |
| Non-Current Assets | 64.6B |
| Long-Term Investments | 891.8m |
| PP&E | 6.9B |
| Intangibles | 50.8B |
| Other Non-Current Assets | 6B |
| Current Liabilities | 8.5B |
| Accounts Payable | 292m |
| Accrued Liabilities | 1.1B |
| Other Current Liabilities | 7.1B |
| Non-Current Liabilities | 17.5B |
| Long-Term Debt | 12.3B |
| Other Non-Current Liabilities | 5.2B |
Earnings Waterfall
Hapvida Participacoes e Investimentos SA
|
Revenue
|
27.4B
BRL
|
|
Cost of Revenue
|
-20.3B
BRL
|
|
Gross Profit
|
7.1B
BRL
|
|
Operating Expenses
|
-6.1B
BRL
|
|
Operating Income
|
996.6m
BRL
|
|
Other Expenses
|
-1.7B
BRL
|
|
Net Income
|
-739.2m
BRL
|
Free Cash Flow Analysis
Hapvida Participacoes e Investimentos SA
HAPV3 Profitability Score
Profitability Due Diligence
Hapvida Participacoes e Investimentos SA's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
Hapvida Participacoes e Investimentos SA's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
HAPV3 Solvency Score
Solvency Due Diligence
Hapvida Participacoes e Investimentos SA's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Score
Hapvida Participacoes e Investimentos SA's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HAPV3 Price Targets Summary
Hapvida Participacoes e Investimentos SA
According to Wall Street analysts, the average 1-year price target for
HAPV3
is 5.9 BRL
with a low forecast of 4.95 BRL and a high forecast of 7.35 BRL.
Shareholder Return
HAPV3 Price
Hapvida Participacoes e Investimentos SA
| Average Annual Return | 11.29% |
| Standard Deviation of Annual Returns | 76.61% |
| Max Drawdown | -89% |
| Market Capitalization | 28.9B BRL |
| Shares Outstanding | 7 495 107 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Hapvida Participacoes e Investimentos SA
Country
Industry
Market Cap
Dividend Yield
Description
Hapvida Participações e Investimentos SA operates hospitals and clinics. The company is headquartered in Fortaleza, Ceara. The company went IPO on 2018-04-25. The firm and its subsidiaries main activities are the coverage of costs of medical, hospital and dental care of its associates, the provision of medical, hospital and dentistry services and examinations and diagnoses per image. Hapvida has different healthcare facilities such as hospitals, clinics or diagnostic imaging units. The firm operates in the Northeast of Brazil, in more than 10 states such as Alagoas, Amazonas, Bahia, Pernambuco, Rio Grande do Norte, Sergipe, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one
HAPV3
stock under the Base Case scenario is
6.33
BRL.
Compared to the current market price of 3.85 BRL,
Hapvida Participacoes e Investimentos SA
is
Undervalued by 39%.
You don't have any saved screeners yet
